Agenda

Front Matter: 5 minutes
Participation in Activity: 1 hour 45 minutes
Post-test: 5 minutes
Evaluation: 5 minutes

Program Overview

This 2-hour, video slide show, CHB Squares: Face-Off with Hepatitis B Experts at Clinical Decision Points, will utilize case presentations to review the clinical data influencing management of patients with chronic hepatitis B (CHB). Presentations will highlight optimal treatment strategies based on current professional guidelines, as well as recent clinical data and expert insights. In addition, these presentations will identify strategies to prevent and/or manage antiviral resistance, and provide strategies to monitor and treat persons with CHB and liver disease.

Target Audience

This activity is designed for hepatologists and gastroenterologists who treat patients with chronic hepatitis B.

Educational Objectives

Upon completing this program, participants will be better able to:

• Describe how the AASLD guidelines for treating and monitoring persons for CHB can be incorporated into routine clinical practice
• Select treatment strategies for persons with CHB based on an understanding of the AASLD guidelines
  
• Identify strategies to prevent and/or manage antiviral resistance in the long-term management of patients with CHB
• Explain how to monitor and treat persons with CHB and liver disease to prevent further disease progression

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and HealthmattersCME. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Robert S. Brown, MD, MPH
Consulting Fees: Gilead Sciences, Inc.
Honoraria: Gilead Sciences, Inc.

K. Rajender Reddy, MD
Consulting Fees: Gilead Sciences, Inc.; Merck; Roche Pharmaceuticals/Genentech; Tibotec Therapeutics; Vertex
Contracted Research: Anadys; Bristol-Myers Squibb; Gilead Sciences, Inc.; Merck; Roche Pharmaceuticals/Genentech; Tibotec Therapeutics

Eugene R. Schiff, MD, MACP, FRCP, MACG, AGAF
Consulting Fees: Gilead Sciences, Inc.
Contracted Research: Abbott Diagnostics; Beckman; Bristol-Myers Squibb; Gilead Sciences, Inc.; Ortho Clinical Diagnostics; Siemens
Scientific Advisory Board: Bristol-Myers Squibb; Gilead Sciences, Inc.

Mark Sulkowski, MD
Consulting Fees: Abbott, Inc; Boehringer Ingelheim; Gilead Sciences, Inc.; Merck; Pfizer Inc.; Pharmasset; Roche Pharmaceuticals/Genentech; Tibotec Therapeutics; Vertex
Contracted Research: (With funds paid to Johns Hopkins University) Abbott, Inc; Boehringer Ingelheim; Merck; Pharmasset; Roche Pharmaceuticals/Genentech; Tibotec Therapeutics; Vertex

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Jackie Dawson, MSN: Nothing to disclose

Amanda Glazar, PhD: Nothing to disclose

James Murphy: Nothing to disclose

Disclaimer OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Gilead Sciences, Inc., do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information

There is no fee to participate in this activity.

GLOBAL CONTACT INFORMATION

For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@ globaleducationgroup.com

In order to receive credit for this activity, the participant must participate in the activity, and completed the Post Test with a score of 70% or better and complete the Evaluation.

Media

• Internet Activity

System Requirements